US Broker Ratings

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unveiling a Potential 189% Upside in the Biotechnology Sector

Structure Therapeutics Inc. (NASDAQ: GPCR) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at addressing chronic diseases with significant unmet..

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Frontier with an 11.28% Potential Upside

Teladoc Health, Inc. (TDOC), a key player in the ever-evolving healthcare industry, has captured the attention of investors with its robust virtual healthcare services and a..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: 29.83% Upside Potential with Innovative Spinal Solutions

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing the attention of investors with..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a 115% Potential Upside for Savvy Investors

Innoviva, Inc. (INVA), a biotechnology company based in Burlingame, California, is making waves in the healthcare sector with its promising stock potential. With a market cap..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 32.91% Potential Upside in the Healthcare Sector

10x Genomics, Inc. (NASDAQ: TXG) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Pleasanton, California, this life..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 146.60% Upside Amidst Market Challenges

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, offers a diverse portfolio in diagnostics and pharmaceuticals that caters to both domestic and..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Innovator with a 31% Potential Upside

Tarsus Pharmaceuticals, Inc. (TARS) is capturing the attention of investors with its compelling growth narrative and significant market potential in the healthcare sector. As a commercial-stage..

Liquidia Corporation (LQDA) Stock Analysis: Biotechnology Innovator Shows 60.82% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the biotechnology industry, stands out with a robust 60.82% potential upside according to analyst ratings. As the company..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Promising 117% Upside in the Biotechnology Sector

Vera Therapeutics, Inc. (NASDAQ: VERA) is positioning itself as a potentially high-reward player in the biotechnology sector, with its focus on developing transformative treatments for serious..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 5.87% Potential Upside in the Dental Industry

Envista Holdings Corporation (NYSE: NVST) is a notable player within the healthcare sector, specifically focusing on the medical instruments and supplies industry. With a market capitalization..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a Potential 16.47% Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART) stands as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 231% Potential Upside in Biotech

Janux Therapeutics, Inc. (NASDAQ: JANX), a pioneer in the field of biopharmaceuticals, has been turning heads in the investment community with its innovative approach to cancer..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Valuation and Growth Prospects Amidst Analyst Optimism

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector’s niche of medical instruments and supplies, has been making waves with its unique business..

89bio, Inc. (ETNB) Stock Analysis: Unpacking the 127.89% Potential Upside

89bio, Inc. (NASDAQ: ETNB) is making waves in the biotechnology sector with its promising pipeline in the treatment of liver and cardio-metabolic diseases. With a market..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 224.67% Potential Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN) stands as a compelling player in the biotechnology sector, offering a promising yet complex profile for investors seeking growth investments. With a..

GRAIL, Inc. (GRAL) Stock Analysis: High Current Price Amidst Downside Risks

GRAIL, Inc. (NASDAQ: GRAL) has emerged as a significant player in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 26% Potential Upside in the Biopharmaceutical Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has increasingly captured the attention of investors in the healthcare sector. With its focus on developing novel therapies for cardiovascular and..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring an 82.96% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands as a dynamic player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 7.4% Potential Upside in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, particularly in the medical care facilities industry, has been garnering attention from investors..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 53% Potential Upside Amidst a Biotech Revolution

For investors eyeing the healthcare sector, Disc Medicine, Inc. (NASDAQ: IRON) presents a compelling opportunity. With a focus on addressing unmet needs in hematologic diseases, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds